Biolux Research Holdings, Inc. announced that it will receive $16,189,119.10440 in funding on April 25, 2019. The company will issue 15,705,393 series A convertible preferred shares at a price of $1.0308 per share in the transaction. The preferred shares will be convertible in common shares at a price of $1.0308 per share. The company will raise $13,999,997 pursuant to exemption provided under Regulation D. The round will be raised at post money valuation of $16,189,119.